SCHEMBL7914915

SCHEMBL7914915

Brc1cccc(Oc2nnc(-c3ccccc3)c3ccccc23)c1

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.61
NPSR1 Q6W5P4 5/20 0.61
LMNA P02545 4/20 0.61
KMT2A Q03164 4/20 0.59
ALDH1A1 P00352 4/20 0.59
MEN1 O00255 3/20 0.59
MAPT P10636 1/20 0.59
ABCG2 Q9UNQ0 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.54
EGFR P00533 2/20 0.51
ADORA2A P29274 2/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
GPR55 Q9Y2T6 1/20 0.41
KDR P35968 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27965124 0.85 KMT2A (0.79) HTTNPSR1LMNAKMT2AALDH1A1
SCHEMBL7914973 0.84 NPSR1 (0.73) HTTNPSR1LMNAKMT2AALDH1A1
SCHEMBL7915135 0.83 NPSR1 (0.65) HTTNPSR1LMNAKMT2AALDH1A1
SCHEMBL7913320 0.83 NPSR1 (0.61) HTTNPSR1LMNAKMT2AALDH1A1
SCHEMBL7904890 0.83 NPSR1 (0.61) HTTNPSR1LMNAKMT2AALDH1A1
SCHEMBL7913387 0.83 NPSR1 (0.87) HTTNPSR1LMNAKMT2AALDH1A1
SCHEMBL7914758 0.83 NPSR1 (0.61) HTTNPSR1LMNAKMT2AALDH1A1
SCHEMBL7904969 0.78 HTT (0.58) HTTNPSR1LMNAKMT2AALDH1A1
SCHEMBL7912079 0.77 MAPT (0.60) HTTNPSR1LMNAKMT2AALDH1A1
SCHEMBL7913357 0.76 NPSR1 (0.56) HTTNPSR1LMNAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207666-B1 TREATING PRECANCEROUS LESIONS BY ADMINISTERING 4-PHENYLPHTHALAZINE DERIVATIVE CELL PATHWAYS, INC. 2001-03-27 US disclosed